Author Login

Correspondence to Author: Lucio Gordan MD¹ , H. H. Nivita Singh-Bulkan PA-C MS, Amanda Warner MS BSN¹ . Joshua Eaves BA¹ , David Wenk MD¹ , Matthew Fink MD¹ , Ryan Ciarrocchi¹. 

President / Managing Physician Chair of Executive Board Florida Cancer Specialists & Research Institute.
Director, Real-World Evidence Florida Cancer Specialists & Research Institute.
Florida Cancer Specialists & Research Institute.

DOI: 10.52338/tajoph.2025.5171

PURPOSE:

The cost of cancer care in the United States remains a significant concern, particularly considering the rising expenditures associated with oncology services1. Cancer related financial toxicity - the economic burden of cancer care to patients and their families - has increasingly become a critical factor when evaluating quality-of-care. A notable area of distinction between community oncology practices and hospital-based oncology practices arises not from pathway, but from cost. Community oncology practices represent a valuable resource to mitigate financial toxicity by providing affordable, clinically equivalent care at significantly less cost. This review explores the factors contributing to cost differences, supported by scientific literature and empirical evidence.

Citation:

Dr. Lucio Gordan MD,The Role Of Utilizing Community Oncology Care To Decrease Cancer-Related Financial Toxicity. The American Journal of Public Health 2025.